Overwhelming demand for transformative GLP-1 agonists like Ozempic and Mounjaro has led to widespread compounding and a boom in counterfeiting.

Several states are trying to reduce healthcare costs by importing medicine from countries where it costs less, but this is a deeply flawed policy proposal.

Pharmacy Benefit Managers' under-reimbursements make pharmacies perfect targets for counterfeiters—and make the U.S. drug supply less safe as a result.

State Prescription Drug Affordability Boards intend to control medicine costs — but some of their strategies will have unintended consequences.

After two decades of tracking counterfeit drugs, PSM is an expert on medicine safety issues and we often offer journalists our insight and perspective. 

PSM applauds Arkansas Board of Pharmacy for protecting patients

February 14, 2025

The Partnership for Safe Medicines applauds the Arkansas State Board of Pharmacy for utilizing new product verification technology for identifying illegitimate Ozempic quarantined by a pharmacy this week.

February 10, 2025: NY woman allegedly injected mystery substances instead of Botox

February 10, 2025
A woman's neck frings with layers of red welts

Mystery cosmetic injections allegedly harmed a client in Queens. PSM addressed a misleading drug ad for compounded weight loss medicine.

Over 100 million Americans just watched a misleading ad at the Super Bowl.

February 9, 2025

You could tell an American that they’re getting a compounded medicine and they would have no idea what that meant.  That may be a legal disclosure, but that’s not good enough to protect patients who don’t know what the words mean.

Letter to FDA’s Office of Prescription Drug Promotion, CDER

February 5, 2025

PSM sent the following letter to the FDA’s Office of Prescription Drug Promotion (CDER) asking them to enforce the laws and guidelines that protect Americans from misleading advertising in the Hims&Hers Super Bowl ad.

Letter to Fox Corporation regarding misleading Hims&Hers Super Bowl ad

February 5, 2025

PSM sent the attached letter to Fox Broadcasting, calling on them to withdraw the deeply troubling and misleading Hims&Hers Super Bowl ad.

February 3, 2025: A New York jury convicts precursor sellers

February 3, 2025

Employees of the now-closed Chinese chemical company Hubei Amarvel Biotech were convicted at trial after shipping more than 200 kilograms of fentanyl precursor chemicals to the U.S. between November 2022 and June 2023.

Like your information on video? Subscribe to our YouTube playlist!

Watch to learn who HSI arrested and why and keep track here. 

youtube-video-thumbnail

The American Diabetes Association warned patients about non-FDA approved  GLP-1 injections. Learn more.

youtube-video-thumbnail

The FTC says PBMs are driving up drug costs. Learn how.

Click the images below to see more recent videos.